AtriCure, Inc. Common Stock
ATRC US04963C2098
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Noznesky Justin J SR OFF |
36.30 USD |
3,000 Sold |
108,900 USD |
12/09/2025 | 12/09/2025 |
Wehrwein Sven |
37.00 USD |
5,000 Sold |
185,000 USD |
22/08/2025 | 22/08/2025 |
Wehrwein Sven |
36.00 USD |
5,000 Sold |
180,000 USD |
19/08/2025 | 19/08/2025 |
Wehrwein Sven |
36.00 USD |
5,000 Sold |
180,000 USD |
19/08/2025 | 19/08/2025 |
Groves Regina E |
36.82 USD |
2,452 Sold |
90,283 USD |
06/08/2025 | 06/08/2025 |
Doraiswamy Vinayak CSO |
36.58 USD |
2,500 Sold |
91,450 USD |
05/08/2025 | 05/08/2025 |
Doraiswamy Vinayak CSO |
33.44 USD |
2,500 Sold |
83,600 USD |
28/05/2025 | 28/05/2025 |
Doraiswamy Vinayak CSO |
33.44 USD |
2,500 Sold |
83,600 USD |
28/05/2025 | 28/05/2025 |
Prange Karen |
38.12 USD |
6,100 Sold |
232,532 USD |
05/03/2025 | 05/03/2025 |
Yuen Maggie |
24.07 USD |
3,500 Sold |
84,245 USD |
15/08/2024 | 15/08/2024 |